{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-087888","form_type":"8-K","ticker":"VSTM","cik":"0001526119","company_name":"Verastem, Inc.","filed_at":"2023-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.195452+00:00","generated_at":"2026-06-12T05:56:22.372495+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Verastem enters CEO employment agreement with Daniel Paterson; $600K salary, equity grants","bullets":["Daniel Paterson appointed President & CEO effective Aug 1, 2023; employment agreement signed Aug 2, 2023.","Base salary $600K/yr; annual bonus target 55% of base salary, pro-rated for 2023.","Granted option for 100,000 shares at $10.44/share; 50,000 time-based RSUs; 50,000 performance-based RSUs tied to FDA acceptance/approval of avutometinib+defactinib NDA.","Time-based awards vest 25% on 1-yr anniversary, then 6.25% quarterly over 4 yrs.","Severance: 12 months salary (18 months upon Change of Control), pro-rata bonus, COBRA, accelerated time-based vesting for 12 months."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-087888","json":"https://secwatch.observer/filing/0001104659-23-087888.json","markdown":"https://secwatch.observer/filing/0001104659-23-087888.md","text":"https://secwatch.observer/filing/0001104659-23-087888.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1526119/000110465923087888/0001104659-23-087888-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1526119/000110465923087888/tm2322911d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T05:56:22.372495+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"480d14e105","claim":"Daniel Paterson was appointed as President and Chief Executive Officer at Verastem, Inc..","evidence_excerpt":"Daniel Paterson was appointed to the position of President and Chief Executive Officer of Verastem, Inc. (the “Company”) effective as of August 1, 2023","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1526119/000110465923087888/0001104659-23-087888-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}